Phrixus Pharma Wins NIH Grants
Phrixus Pharmaceuticals of Ann Arbor, MI has won $890,000 in grants from the National Institutes of Health. The University of Michigan spinoff is developing drugs to treat muscular dystrophy and heart failure.
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Co-Founder, VP of Technology, Entropic Communications
Professor of Systems Biology, Columbia University
VP of Research & Policy, Ewing Marion Kauffman Foundation